1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Methicillin-Resistant Staphylococcus aureus (MRSA) - 5EU Drug Forecast and Market Analysis to 2024

Methicillin-Resistant Staphylococcus aureus (MRSA) - 5EU Drug Forecast and Market Analysis to 2024

  • December 2015
  • 328 pages
  • ID: 3963817
In this report:
ACROSS THE US AND ##EU, GLOBALDATA ANTICIPATES THAT ORBACTIV WILL EXPERIENCE MODEST GROWTH IN THESE AFOREMENTIONED PATIENT POPULATIONS FROM 2014-2024, ACHIEVING PEAK-YEAR SALES OF OVER $##M IN 2020 BEFORE DROPPING BELOW $##M BY 2024, AT AN OVERALL CAGR OF ##.##%.
MORE SPECIFICALLY, ITS WANING SALES WILL BE MOST PRONOUNCED IN GERMANY (NEGATIVE CAGR OF ##.##% FROM 2014-2024), FOLLOWED BY SPAIN (NEGATIVE CAGR OF ##.##% FROM 2014-2024).

Summary

Table of Contents

Search Inside

Methicillin-Resistant Staphylococcus aureus - 5EU Drug Forecast and Market Analysis to 2024

Brief

With the discovery of penicillin, the first naturally-occurring antibiotic, in 1928, and its mass production in the early 1940s, infections with Staphylococcus aureus were mostly treatable, without any main complications. However, clinicians soon observed the emergence of penicillin-resistant strains of S. aureus, which was largely driven by bacterial expression of beta-lactamases. Methicillin, a novel penicillin analogue that was resistant to beta-lactamases, was introduced in 1959, and was initially effective against penicillin-resistant S. aureus strains. However, this success was short-lived, as the first methicillin-resistant S. aureus strain had been identified in the lab by 1961, and cases of MRSA were first observed in the clinic in 1968. Initially, MRSA strains only occurred in small and local outbreaks across the U.S. and Europe (EU), but they can now be found around the globe.

For the purposes of this report, GlobalData defines the 5EU MRSA market as encompassing the sales of antimicrobial agents prescribed for the treatment of hospitalized MRSA skin infections, pneumonia, and bacteremia in France (FR), Germany (DE), Italy (IT), Spain (ES), and the UK. Importantly, revenues generated by these products outside of the aforementioned countries, patient populations, and clinical scenarios are beyond the scope of this analysis.

Overview

- Overview of MRSA including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the challenging landscape.

- Exhaustive information on the top drugs in 5EU including product description, safety and efficacy profiles as well as a SWOT analysis.

- Sales forecast for the best drugs in 5EU from 2014-2024.

- Analysis of the impact of main events as well the drivers and restraints affecting 5EU MRSA market.

Great reasons to purchase

- Understand and capitalize by identifying products that are most likely to ensure a strong return

- Stay ahead of the competition by understanding the changing ambitious landscape for MRSA.

- Effectively plan your M&A and partnership strategies by identifying drugs with the most favorable sales plausible

- Make more informed business decisions from insightful and detailed analysis of drug performance

- Obtain sales forecast for drugs from 2014-2024 in 5EU.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Veronica helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
2018 Global Clinical Chemistry and Immunodiagnostics Market: US, Europe, Japan--Analyzers and Reagents-- Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

2018 Global Clinical Chemistry and Immunodiagnostics Market: US, Europe, Japan--Analyzers and Reagents-- Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 23500
  • Industry report
  • June 2018
  • by Venture Planning Group

The report is a seven-country strategic analysis of major business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report explores future ...

Immunodiagnostics: Spot Fast-Growing Market Segments--Therapeutic Drug Monitoring, Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse

Immunodiagnostics: Spot Fast-Growing Market Segments--Therapeutic Drug Monitoring, Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse

  • $ 15900
  • Industry report
  • June 2018
  • by Venture Planning Group

This comprehensive seven-country report contains 1,115 pages and 450 tables. The report explores future trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; ...

2018 Europe Clinical Chemistry and Immunodiagnostic Analyzers and Reagents Market: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts

2018 Europe Clinical Chemistry and Immunodiagnostic Analyzers and Reagents Market: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts

  • $ 12800
  • Industry report
  • June 2018
  • by Venture Planning Group

Complete report $19,700.DataPack (test volumes, sales forecasts, supplier shares) $12,800.This comprehensive five-country report contains 900 pages and 335 tables. The report explores future trends in ...


ref:plp2015

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on